Late-extended adjuvant treatment: Does it work?

Diana Crivellari

Research output: Contribution to journalArticle

Abstract

Data from the National Institute of Canada IVIA.1 7 trial showed that patients who were disease free after 5 years of adjuvant treatment with tamoxifen had a 42% reduction of breast cancer recurrences (p <0.001) when they received a further treatment with the nonsteroidalJ aromatase inhibitor letrozole, immediately or within 3 montihs from the end of tamoxifen.

Original languageEnglish
Pages (from-to)237-240
Number of pages4
JournalAging Health
Volume4
Issue number3
DOIs
Publication statusPublished - Jun 2008

Fingerprint

letrozole
Tamoxifen
Aromatase Inhibitors
Canada
Breast Neoplasms
Recurrence
Therapeutics

Keywords

  • Aromatase inhibitors
  • Extended adjuvant therapy
  • Letrozole

ASJC Scopus subject areas

  • Medicine(all)
  • Geriatrics and Gerontology

Cite this

Late-extended adjuvant treatment : Does it work? / Crivellari, Diana.

In: Aging Health, Vol. 4, No. 3, 06.2008, p. 237-240.

Research output: Contribution to journalArticle

Crivellari, Diana. / Late-extended adjuvant treatment : Does it work?. In: Aging Health. 2008 ; Vol. 4, No. 3. pp. 237-240.
@article{062e2aa4a6a241d99f7fa4b9781569c1,
title = "Late-extended adjuvant treatment: Does it work?",
abstract = "Data from the National Institute of Canada IVIA.1 7 trial showed that patients who were disease free after 5 years of adjuvant treatment with tamoxifen had a 42{\%} reduction of breast cancer recurrences (p <0.001) when they received a further treatment with the nonsteroidalJ aromatase inhibitor letrozole, immediately or within 3 montihs from the end of tamoxifen.",
keywords = "Aromatase inhibitors, Extended adjuvant therapy, Letrozole",
author = "Diana Crivellari",
year = "2008",
month = "6",
doi = "10.2217/1745509X.4.3.237",
language = "English",
volume = "4",
pages = "237--240",
journal = "Aging Health",
issn = "1745-509X",
publisher = "Future Medicine Ltd.",
number = "3",

}

TY - JOUR

T1 - Late-extended adjuvant treatment

T2 - Does it work?

AU - Crivellari, Diana

PY - 2008/6

Y1 - 2008/6

N2 - Data from the National Institute of Canada IVIA.1 7 trial showed that patients who were disease free after 5 years of adjuvant treatment with tamoxifen had a 42% reduction of breast cancer recurrences (p <0.001) when they received a further treatment with the nonsteroidalJ aromatase inhibitor letrozole, immediately or within 3 montihs from the end of tamoxifen.

AB - Data from the National Institute of Canada IVIA.1 7 trial showed that patients who were disease free after 5 years of adjuvant treatment with tamoxifen had a 42% reduction of breast cancer recurrences (p <0.001) when they received a further treatment with the nonsteroidalJ aromatase inhibitor letrozole, immediately or within 3 montihs from the end of tamoxifen.

KW - Aromatase inhibitors

KW - Extended adjuvant therapy

KW - Letrozole

UR - http://www.scopus.com/inward/record.url?scp=48249104017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48249104017&partnerID=8YFLogxK

U2 - 10.2217/1745509X.4.3.237

DO - 10.2217/1745509X.4.3.237

M3 - Article

AN - SCOPUS:48249104017

VL - 4

SP - 237

EP - 240

JO - Aging Health

JF - Aging Health

SN - 1745-509X

IS - 3

ER -